» Articles » PMID: 35317228

Analysis Methods for the Gut Microbiome in Neuropsychiatric and Neurodegenerative Disorders

Overview
Specialty Biotechnology
Date 2022 Mar 23
PMID 35317228
Authors
Affiliations
Soon will be listed here.
Abstract

For a long time, the central nervous system was believed to be the only regulator of cognitive functions. However, accumulating evidence suggests that the composition of the microbiome is strongly associated with brain functions and diseases. Indeed, the gut microbiome is involved in neuropsychiatric diseases (e.g., depression, autism spectrum disorder, and anxiety) and neurodegenerative diseases (e.g., Parkinson's disease and Alzheimer's disease). In this review, we provide an overview of the link between the gut microbiome and neuropsychiatric or neurodegenerative disorders. We also introduce analytical methods used to assess the connection between the gut microbiome and the brain. The limitations of the methods used at present are also discussed. The accurate translation of the microbiome information to brain disorder could promote better understanding of neuronal diseases and aid in finding alternative and novel therapies.

Citing Articles

Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS.

Noemi C, Bob P, Bokkon I Curr Neuropharmacol. 2024; 22(13):2100-2112.

PMID: 38726788 PMC: 11337685. DOI: 10.2174/1570159X22666240507095700.


Gut microbiota and autism spectrum disorders: where do we stand?.

Zyoud S, Shakhshir M, Abushanab A, Koni A, Shahwan M, Jairoun A Gut Pathog. 2023; 15(1):50.

PMID: 37880713 PMC: 10601286. DOI: 10.1186/s13099-023-00575-8.


Neutrophils as a potential therapeutic target in Alzheimer's disease.

Aries M, Hensley-McBain T Front Immunol. 2023; 14:1123149.

PMID: 36936930 PMC: 10020508. DOI: 10.3389/fimmu.2023.1123149.


Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders.

Marc M, Jastrzab R, Mytych J Nutrients. 2022; 14(19).

PMID: 36235622 PMC: 9571089. DOI: 10.3390/nu14193967.

References
1.
Bull-Larsen S, Mohajeri M . The Potential Influence of the Bacterial Microbiome on the Development and Progression of ADHD. Nutrients. 2019; 11(11). PMC: 6893446. DOI: 10.3390/nu11112805. View

2.
Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

3.
Galloway-Pena J, Hanson B . Tools for Analysis of the Microbiome. Dig Dis Sci. 2020; 65(3):674-685. PMC: 7598837. DOI: 10.1007/s10620-020-06091-y. View

4.
Chen M, Wang S, Kuo C, Tsai I . Metabolome analysis for investigating host-gut microbiota interactions. J Formos Med Assoc. 2018; 118 Suppl 1:S10-S22. DOI: 10.1016/j.jfma.2018.09.007. View

5.
Ioannides Z, Ngo S, Henderson R, McCombe P, Steyn F . Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression. Neurodegener Dis. 2016; 16(5-6):382-97. DOI: 10.1159/000446502. View